MARIMO cells harbor a CALR mutation but are not dependent on JAK2/STAT5 signaling

被引：31
|
作者：
Kollmann, K. [1 ,2 ]
Nangalia, J. [1 ,2 ,3 ,4 ]
Warsch, W. [1 ,2 ]
Quentmeier, H. [5 ]
Bench, A. [4 ]
Boyd, E. [4 ]
Scott, M. [4 ]
Drexler, H. G. [5 ]
Green, A. R. [1 ,2 ,4 ]
机构：
[1] Univ Cambridge, Wellcome Trust MRC Stem Cell Inst, Cambridge Inst Med Res, Cambridge, England
[2] Univ Cambridge, Dept Haematol, Cambridge, England
[3] Wellcome Trust Sanger Inst, Cambridge, England
[4] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
[5] German Collect Microorganisms & Cell Cultures, Leibniz Inst DSMZ, Braunschweig, Germany
来源：
LEUKEMIA | 2015年 / 29卷 / 02期
关键词：
MYELOPROLIFERATIVE NEOPLASMS; ESSENTIAL THROMBOCYTHEMIA; MYELOFIBROSIS; RETICULUM; JAK2; CALRETICULIN; INHIBITOR;
D O I：
10.1038/leu.2014.285
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：494 / 497
页数：5
相关论文
共 50 条
  • [41] RETRACTED: PRL/PRLR Can Promote Insulin Resistance by Activating the JAK2/STAT5 Signaling Pathway (Retracted Article)
    Wang, Pei-yu
    Jin, Cong-cong
    Liu, Chang
    Zhao, Zhou-jian
    Yang, Hai-yan
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [42] Development of a novel ligand that activates JAK2/STAT5 signaling through a heterodimer of prolactin receptor and growth hormone receptor
    Langenheim, John Fairbanks
    Chen, Wen Yuan
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2009, 29 (02) : 107 - 112
  • [43] REGULATORY NETWORKS OF JAK2/STAT5 PATHWAY ACTIVITY IN MYELOPROLIFERATIVE NEOPLASIA CELL LINES
    Salas Cintora, E. M.
    Garcia-Barchino, M. J.
    Vizmanos, J. L.
    Novo, F. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 400 - 400
  • [44] The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma (vol 16, pg 55, 2018)
    Keller, A.
    Wingelhofer, B.
    Peter, B.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2019, 17 (03) : 446 - 447
  • [45] Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice
    Miquet, JG
    Sotelo, AI
    Bartke, A
    Turyn, D
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 289 (04): : E600 - E607
  • [46] Multitargeted tyrosine kinase inhibitor stimulates expression of IL-6 and activates JAK2/STAT5 signaling in acute myelogenous leukemia cells
    Nishioka, C.
    Ikezoe, T.
    Yang, J.
    Yokoyama, A.
    LEUKEMIA, 2009, 23 (12) : 2304 - 2308
  • [47] Multitargeted tyrosine kinase inhibitor stimulates expression of IL-6 and activates JAK2/STAT5 signaling in acute myelogenous leukemia cells
    C Nishioka
    T Ikezoe
    J Yang
    A Yokoyama
    Leukemia, 2009, 23 : 2304 - 2308
  • [48] JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms
    Shirane, Shuichi
    Araki, Marito
    Morishita, Soji
    Edahiro, Yoko
    Takei, Hiraku
    Yoo, Yongjin
    Choi, Murim
    Sunami, Yoshitaka
    Hironaka, Yumi
    Noguchi, Masaaki
    Koike, Michiaki
    Noda, Naohiro
    Ohsaka, Akimichi
    Komatsu, Norio
    HAEMATOLOGICA, 2015, 100 (02) : E46 - E48
  • [49] JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin-induced beta-lactoglobulin transcription
    Han, YL
    Watling, D
    Rogers, NC
    Stark, GR
    MOLECULAR ENDOCRINOLOGY, 1997, 11 (08) : 1180 - 1188
  • [50] Overexpression of erythropoietin in sertoli cells enhances testosterone production in leydig cells through activation of JAK2/STAT5 but not map kinases
    Goda, K
    Fujisawa, M
    Shirakawa, T
    Dobashi, M
    Kondo, Y
    Gotoh, A
    Okada, H
    Kamidono, S
    JOURNAL OF UROLOGY, 2004, 171 (04): : 362 - 362
12345